TRIPHARM: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
TRIPHARM
Largest movements
- Current investments +€24,145
up €24,145 (+33.8%), from €71,422 to €95,567
- Tangible fixed assets -€8,614
down €8,614 (-22.8%), from €37,854 to €29,240
of which Furniture and vehicles: -€10,231
- Cash +€7,453
up €7,453 (+3.8%), from €194,797 to €202,250
mainly Net result for the year (+€19,829) and Debts after one year (+€15,432)
- Reserves +€19,829
up €19,829 (+10.8%), from €182,865 to €202,693
- Debts after one year +€15,432
up €15,432 (+9.3%), from €166,597 to €182,029
- Accrued charges and deferred income -€5,034
down €5,034 (-29.0%), from €17,375 to €12,341
- Financial income -€18,171
down €18,171 (-94.3%), from €19,278 to €1,107
- Taxes -€1,417
down €1,417 (-11.3%), from €12,585 to €11,167
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €398,396 | €424,878 | +€26,481 | +6.6% |
| Fixed assets | 21/28 | €87,854 | €79,240 | -€8,614 | -9.8% |
| Tangible fixed assets | 22/27 | €37,854 | €29,240 | -€8,614 | -22.8% |
| Plant, machinery and equipment | 23 | €1,162 | €2,779 | +€1,617 | +139.1% |
| Furniture and vehicles | 24 | €36,692 | €26,461 | -€10,231 | -27.9% |
| Financial fixed assets | 28 | €50,000 | €50,000 | = | 0.0% |
| Current assets | 29/58 | €310,543 | €345,638 | +€35,095 | +11.3% |
| Amounts receivable within one year | 40/41 | €43,565 | €47,226 | +€3,661 | +8.4% |
| Trade receivables | 40 | €43,560 | €46,086 | +€2,526 | +5.8% |
| Other amounts receivable | 41 | €5 | €1,140 | +€1,135 | +21410.9% |
| Current investments | 50/53 | €71,422 | €95,567 | +€24,145 | +33.8% |
| Cash at bank and in hand | 54/58 | €194,797 | €202,250 | +€7,453 | +3.8% |
| Deferred charges and accrued income | 490/1 | €759 | €595 | -€164 | -21.6% |
| Total equity and liabilities | 10/49 | €398,396 | €424,878 | +€26,481 | +6.6% |
| Equity | 10/15 | €201,465 | €221,293 | +€19,829 | +9.8% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €182,865 | €202,693 | +€19,829 | +10.8% |
| Distributable reserves | 133 | €182,865 | €202,693 | +€19,829 | +10.8% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €196,932 | €203,584 | +€6,652 | +3.4% |
| Amounts payable after more than one year | 17 | €166,597 | €182,029 | +€15,432 | +9.3% |
| Other amounts payable | 178/9 | €166,597 | €182,029 | +€15,432 | +9.3% |
| Amounts payable within one year | 42/48 | €12,959 | €9,214 | -€3,746 | -28.9% |
| Trade debts | 44 | €1,189 | €887 | -€302 | -25.4% |
| Suppliers | 440/4 | €1,189 | €887 | -€302 | -25.4% |
| Taxes, remuneration and social security | 45 | €7,798 | €7,853 | +€55 | +0.7% |
| Taxes | 450/3 | €7,798 | €7,853 | +€55 | +0.7% |
| Other amounts payable | 47/48 | €3,973 | €473 | -€3,500 | -88.1% |
| Accrued charges and deferred income | 492/3 | €17,375 | €12,341 | -€5,034 | -29.0% |
| Non-recurring operating income | 76A | €0 | - | = | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €11,141 | €10,798 | -€343 | -3.1% |
| Other operating charges | 640/8 | €778 | €769 | -€9 | -1.1% |
| Gross operating margin | 9900 | €54,076 | €53,885 | -€191 | -0.4% |
| Operating profit (loss) | 9901 | €42,157 | €42,318 | +€161 | +0.4% |
| Financial income | 75/76B | €19,278 | €1,107 | -€18,171 | -94.3% |
| Recurring financial income | 75 | €19,278 | €1,107 | -€18,171 | -94.3% |
| Financial charges | 65/66B | €12,676 | €12,429 | -€247 | -1.9% |
| Recurring financial charges | 65 | €12,676 | €12,429 | -€247 | -1.9% |
| Profit (loss) for the period before taxes | 9903 | €48,759 | €30,996 | -€17,763 | -36.4% |
| Income taxes | 67/77 | €12,585 | €11,167 | -€1,417 | -11.3% |
| Profit (loss) for the period | 9904 | €36,174 | €19,829 | -€16,345 | -45.2% |
| Profit (loss) for the period to be appropriated | 9905 | €36,174 | €19,829 | -€16,345 | -45.2% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.